You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

retroviral transduction

Showing 1 - 25 of 379
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

Severe Combined Immunodeficiency Trial in Los Angeles (ADA gene transfer)

Completed
Has Results
  • Severe Combined Immunodeficiency
  • ADA gene transfer
  • Los Angeles, California
    University of California, Los Angeles
Apr 21, 2021

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022

HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

Not yet recruiting
  • HIV-1
  • +3 more
  • (no location specified)
Jan 17, 2023

Allogeneic Gamma Delta (?d) CAR T Cells

Enrolling by invitation
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • Stanford, California
  • +4 more
Jun 7, 2022

Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

Recruiting
  • Severe Combined Immunodeficiency Disease, X-linked
  • CL20-i4-EF1α-hγc-OPT
  • +2 more
  • San Francisco, California
  • +2 more
Jan 9, 2023

Sympathetic Transduction in Obesity

Not yet recruiting
  • Hypertension
  • No intervention
  • (no location specified)
Oct 18, 2022

X-linked Severe Combined Immunodeficiency Trial in Paris (Gene transfer)

Completed
  • X-linked Severe Combined Immunodeficiency
  • Gene transfer
  • Paris, France
    Hopital Necker
Sep 22, 2021

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

Inflammation, Cardiovascular Diseases, Zinc Deficiency Trial in Cleveland (Zinc Gluconate, Placebo)

Recruiting
  • Inflammation
  • +2 more
  • Zinc Gluconate
  • Placebo
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jan 8, 2023

B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

Active, not recruiting
  • B-Cell Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Maywood, Illinois
    Loyola University
Aug 11, 2022

Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • MGMTP140K-encoding retroviral vector
  • +6 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022

Frequency of Symptomatic Herpes Virus I and II in HIV Infected

Recruiting
  • HIV Disease
  • +2 more
  • Blood draw
  • Los Angeles, California
    Global Research Institute
Apr 9, 2023

Mature B Cell Tumors Trial in Tianjin (SHR1459)

Active, not recruiting
  • Mature B Cell Neoplasms
  • Tianjin, Tianjin, China
    Blood disease hospital of Chinese Academy of Medical Sciences
Nov 10, 2022

Early Anti-Retroviral Treatment in HIV- Infected Children

Active, not recruiting
  • HIV Infections
  • Blood samples collection
  • Bamako, Mali
  • +5 more
Mar 13, 2023

Patients Who Received Gene-Modified Cell Therapy

Enrolling by invitation
  • Long-term Follow-up
  • Gene-Modified Cell Therapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center Clinical Research Unit, University of Pen
Jul 21, 2022

Vasoconstriction, Vasodilation Trial in Edmonton (Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine

Not yet recruiting
  • Vasoconstriction
  • Vasodilation
  • Phenylephrine Hydrochloride
  • +4 more
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 21, 2023

HIV Seropositivity Trial in Isingiro (Early CCLAD)

Completed
  • HIV Seropositivity
  • Early CCLAD
  • Isingiro, Uganda
    Nakivale Refugee Settlement
May 20, 2022

HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)

Recruiting
  • HIV-1-infection
  • +2 more
  • ASC22 1mg/kg
  • +3 more
  • Beijing, Beijing, China
    The FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022

Human Immunodeficiency Virus Trial in Atlanta (TDF/FTC Dose Schedule for Arm A, TDF/FTC Dose Schedule for Arm B)

Completed
  • Human Immunodeficiency Virus
  • TDF/FTC Dose Schedule for Arm A
  • TDF/FTC Dose Schedule for Arm B
  • Atlanta, Georgia
    Hope Clinic
Sep 20, 2022

MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)

Recruiting
  • Major Depressive Disorder
  • Sildenafil Citrate
  • Placebo oral tablet
  • Shibīn Al Kawm, Egypt
    Faculty of Medicine
Jan 16, 2023

RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome Trial in Roma (Molecular characterization of solid tumor in

Recruiting
  • RASopathy
  • +3 more
  • Molecular characterization of solid tumor in RASopathies
  • Roma, Italy
    Department of Woman and Child Health and Public Health, Fondazio
Feb 27, 2023